Trevi Therapeutics Inc (TRVI)

EBITDA

-$17.78M

Quarterly · Period ending: · USD

TRVI logo

TRVI EBITDA

Latest reported-$17.78M
TRVI Quarterly EBITDA (-$2.22M → -$17.78M)
High-resolution chart · PNG

TRVI ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-17,782,000
-13,178,000
-8,301,000
-11,779,000
-12,284,000
-10,314,000
-11,360,000
-13,236,000
-12,321,000
-10,874,000
-7,764,000
-7,673,000
-6,988,000
-6,158,000
-5,236,000
-7,972,000
-7,753,000
-7,021,000
-8,205,000
-6,937,000
-9,488,000
-8,079,000
-9,185,000
-7,228,000
-7,388,000
-8,472,000
-6,532,000
-7,359,000
-7,407,000
-4,803,000
-6,018,000
-5,675,000
-4,376,000
-3,951,000
-2,221,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.